Coeptis Therapeutics Inc. (COEP)
NASDAQ: COEP
· Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT
Coeptis Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.35 | -1.36 | -19.59 | -17.58 | -17.47 | -36.88 | -24.69 | -54.29 | -15.62 | -38.51 | -173.58 | -105.09 | -0.00 | -165.08 | -171.02 | -371.79 | -512.05 |
PEG Ratio | 0.02 | 0.00 | 0.45 | 4.12 | 0.75 | 0.71 | -0.38 | 0.78 | -0.12 | 1.24 | 4.39 | 1.05 | -0.00 | -47.87 | -1.39 | -10.25 | 5.12 |
PS Ratio | 457.97 | 5.68 | n/a | n/a | n/a | 368.87 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 411.38K | n/a | 53.26K |
PB Ratio | 4.44 | 3.32 | 29.70 | 30.02 | 48.11 | 128.42 | 123.37 | 271.55 | 449.79 | 91.16 | 589.84 | 2K | 1.76K | 797.66 | 57.94 | 61.11 | 58.89 |
P/FCF Ratio | -12.17 | -7.37 | -75.72 | -150.52 | -110.24 | -327.07 | -315.71 | -355.29 | -343.39 | -516.76 | -3.85K | -3.99K | -4.29K | -8.98K | -527.99 | 162.34K | -6.1K |
P/OCF Ratio | -12.17 | -7.37 | -75.72 | -150.52 | -110.24 | -327.07 | -315.71 | -355.29 | -343.39 | -516.76 | -3.85K | -3.99K | -4.29K | -8.98K | -1.11K | 162.34K | -6.1K |
OCF/S Ratio | -37.63 | -0.77 | n/a | n/a | n/a | -1.13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -369.15 | n/a | -8.74 |
Debt / Equity Ratio | 0.31 | 0.44 | 0.37 | 0.25 | 0.56 | 0.28 | 0.20 | 0.82 | 1.32 | 0.36 | 0.57 | 1.89 | 1.67 | 1.74 | 0.06 | 0.01 | 0.03 |
Quick Ratio | 0.82 | 0.23 | 0.40 | 0.55 | 1.60 | 0.59 | 4.10 | 1.37 | 1.15 | 2.16 | 1.71 | 0.56 | 0.87 | 0.79 | 13.55 | 20.70 | 27.22 |
Current Ratio | 0.82 | 0.23 | 0.40 | 0.55 | 1.60 | 0.59 | 2.55 | 1.51 | 1.15 | 2.16 | 1.71 | 0.56 | 0.87 | 0.79 | 12.98 | 20.07 | 26.54 |
Asset Turnover | 0.00 | 0.21 | n/a | n/a | n/a | 0.33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | 0.00 |
Interest Coverage | 56.75 | n/a | -42.06 | -42.81 | -14.58 | -243.35 | -395.53 | -85.33 | -205.28 | -71.87 | -98.7 | -153.74 | -282.54 | 38.29 | -36.85 | -60.89 | -48.94 |
Return on Equity | -0.47 | -0.61 | -0.38 | -0.43 | -0.69 | -0.87 | -1.25 | -1.25 | -7.2 | -0.59 | -0.85 | -4.76 | -1.46M | -1.21 | -0.08 | -0.04 | -0.03 |
Return on Assets | -0.23 | -0.22 | -0.2 | -0.72 | -0.32 | -0.82 | -0.87 | -0.44 | -1.56 | -0.36 | -0.51 | -1.5 | -505.07K | -0.42 | -0.08 | -0.04 | -0.03 |
Return on Invested Capital | -0.37 | -0.25 | -0.3 | -1.32 | -0.4 | -0.81 | -1.22 | -0.57 | -1.38 | -0.39 | -0.53 | -1.66 | -449.21K | -0.46 | -0.09 | -0.03 | -0.02 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.28 | 0.50 | n/a | n/a | n/a | 0.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.85 | n/a | 1.00 |
Net Profit Margin | -48.63 | -1.05 | n/a | n/a | n/a | -2.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -601.37 | n/a | -26 |
Pretax Profit Margin | -54.41 | -1.62 | n/a | n/a | n/a | -2.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -601.37 | n/a | -26 |
Operating Profit Margin | -64.53 | -1.16 | n/a | n/a | n/a | -2.24 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -702.66 | n/a | -22.67 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -64.53 | -1.43 | n/a | n/a | n/a | -2.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -702.66 | n/a | -25.53 |